Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-β isoforms (β1, β2, and β3) during rat cranial suture fusion

Journal of Bone and Mineral Research

Volumn 12, Issue 3, 1997, Pages 311-321

  Roth, Douglas A ^a   Longaker, Michael T ^a   Mccarthy, Joseph G ^a   Rosen, David M ^b   Mcmullen, Heather F ^a   Levine, Jamie P ^a   Sung, Joanne ^a   Gold, Leslie I ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Celtrix Pharmaceuticals   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; GROWTH REGULATION; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; PATHOGENESIS; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

EID: 0030899563     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.3.311     Document Type: Article

References (63)

1. Herring SW 1993 Epigenetic and functional influences on skull growth. In: Hanken J, Hall BK (eds.) The Skull, Vol 1. University of Chicago Press, Chicago, IL, U.S.A.
2. Cohen MM 1993 Sutural biology and the correlates of craniosynostosis. Am J Med Gen 47:581-616.
3. McCarthy JG, Epstein FJ, Wood-Smith D 1990 Craniosynostosis. In: McCarthy JG (ed.) Plastic Surgery, Vol 4. W.B. Saunders Co., Philadelphia, PA, U.S.A., pp. 3013-3053.
4. Marchac D, Renier D 1989 Craniosynostosis. World J Surg 13:358-365.
5. Virchow R 1851 Über den cretinismus, namentlich in franken, and über pathologische schädelformmen, Verh Phys Med Gesellsch Würzbru 2:230-271.
6. Moss ML 1959 The pathogenesis of premature cranial synostosis in man. Acta Anat 37:351-370.
7. Baylink DJ, Finkelman RD, Mohan S 1993 Growth factors to stimulate bone formation. J Bone Miner Res 8:S565-S572.
8. Mundy GR 1993 Cytokines of bone. In: Mundy GR, Martin TJ (eds.) Physiology and Pharmacology of Bone: Handbook of Experimental Pharmacology. Springer, New York, NY, U.S.A., pp. 185-214.
9. Mohan S, Baylink DJ 1991 Bone growth factors. Clin Orthop Rel Res 263:30-48.
10. Goldring MB, Goldring SR 1993 Skeletal tissue response to cytokines. Portland Bone Symp 6:1-132.
11. Preston RA, Post JC, Keats BJB, Aston CE, Ferrell RE, Priest J, Noure N, Losken HW, Morris CA, Hurtt MR, Mulvihill JJ, Ehrlich GD 1994 A gene for Crouzon craniofacial dysostosis maps to the long arm of chromosome 10. Nature Genet 7:149-153.
12. Reardon W, Winter RM, Rutland P, Puleyn LJ, Jones BM, Malcolm S 1994 Mutations in the fibroblastic growth factor receptor 2 gene cause Crouzon Syndrome. Nature Genet 8:98-103.
13. Jabs E, Li X, Scott AF, Meyers G, Chen W, Eccles M, Mao J, Charnas LR, Jackson CE, Jaye M 1994 Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nature Genet 8:275-279.
14. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S, Winter RM 1994 A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer Syndrome. Nature Genet 8:269-274.
15. Schell UL, Hehr A, Feldman GJ, Robin NH, Zackal EH, de Die-Smulders C, Viskochil DH, Stewart JM, Wolff G, Ohashi H, Price RA, Cohen Jr MM, Muenke M 1995 Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Human Mol Genet 4:323-328.
16. Massague J 1990 The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641.
17. Kingsley D 1994 The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146.
18. Roberts AB, Sporn MB 1993 Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8:1-9.
19. Levine JH, Moses HL, Gold LI, Nanney LB 1993 Spatial and temporal patterns of immunoreactive transforming growth factor βl, β2, and 03 during excisional wound repair. Am J Pathol 143:268-380.
20. McMullen H, Longaker MT, Cabrera RC, Sung J, Canete J, Siebert JW, Lorenz P, Gold LI 1995 Spatial and temporal expression of TGF-β isoforms (TGF-βl, TGF-β2, and TGF-β3) during ovine excisional and incisional wound repair. Wound Repair Regen 3:141-156.
21. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI 1991 Immunohistochemical localization of TGF-βl, TGF-β2, and TGF-β3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105.
22. Seyedin SM, Thomas TC, Thompson AY, Rosen DM, Piez KA 1985 Purification and characterization of two cartilage-inducing factors from bovine bone. Proc Natl Acad Sci USA 82:2267-2271.
23. Joyce ME, Roberts AB, Sporn MB, Bolander ME 1990 Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 110:2195-2207.
24. Centrella M, McCarthy TL, Canalis E 1988 Skeletal tissue and transforming growth factor-β. FASEB J 2:3066-3077.
25. Cheifetz S, Weatherbee JA, Tsang MLS, Anderson JK, Mole JE, Lucas R, Massague J 1987 The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell 48:409-415.
26. Seyedin PR, Segarini PR, Rosen DM, Thompson AY, Bentz H, Graycar J 1987 Cartilage-inducing factor-β is a unique protein structurally and functionally related to transforming growth factor-β. J Biol Chem 262:1946-1949.
27. Sporn MB, Roberts AB 1988 Peptide growth factors are multifunctional. Nature 332:217-219.
28. Joyce ME, Terek RM, Jingushi S, Bolander ME 1990 Role of transforming growth factor-β in fracture repair. Ann NY Acad Sci 593:107-123.
29. Rosen DM, Nathan R, Armstrong R, Bentz H, Thompson A, De Leon E, Buckman E, Fiedler L, Seyedin S 1990 Bone induction and transforming growth factor-β. Ann NY Acad Sci 593:98-106.
30. Centrella M, Massague J, Canalis E 1986 Human platelet-derived transforming growth factor-β stimulates parameters of bone growth in fetal rat calvariae. Endocrinology 119:2306-2312.
31. Centrella M, McCarthy TL, Canalis E 1987 Mitogenesis in fetal rat bone cells simultaneously exposed to type β transforming growth factor and other growth regulators. FASEB J 1:312-317.
32. Robey PG, Young MF, Flanders KC, Roche NS, Kondaiah P, Reddi AH, Termine JD, Sporn MB, Roberts AB 1987 Osteoblasts synthesize and respond to transforming growth factor-type β (TGF-β) in vitro. J Cell Biol 105:457-463.
33. Lundy MW, Hendrix T, Wergedal JE, Baylink DJ 1991 Growth factor-induced proliferation of osteoblasts measured by bromodeoxyuridine immunohistochemistry. Growth Factors 4: 257-264.
34. Carrington JL, Roberts AB, Flanders KC, Roche NS, Reddi AH 1988 Accumulation, localization, and compartmentation of transforming growth factor-β during endochondral bone development. J Cell Biol 107:1969-1975.
35. Noda M, Camilliere JJ 1989 In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology 124:2991-2994.
36. Marcelli C, Yates AJ, Mundy GR 1990 In vivo effects of human recombinant transforming growth factor- on bone turnover in normal mice. J Bone Miner Res 5:1087-1096.
37. Mackie EJ, Trechsel U 1990 Stimulation of bone formation in vivo by transforming growth factor-β: Remodeling of woven bone and lack of inhibition by indomethacin. Bone 11:295-300.
38. 1 induces bone closure of skull defects. J Bone Miner Res 6:1257-1265.
39. 1. J Bone Miner Res 8:753-761.
40. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF 1987 Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 237:1333-1336.
41. Shah M, Foreman DM, Ferguson MWJ 1994 Neutralising antibody to TGF-β1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 107:1137-1157.
42. Amento EP, Beck LS 1991 TGF-β and wound healing. In: Clinical Applications of TGF-β. Ciba Foundation Symposium 157. Wiley, Chichester, U.K., pp. 115-129.
43. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS 1986 Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171.
44. Ksander GA, Ogawa Y, Chu GH, McMullin H, Rosenblatt JS, McPherson JM 1990 Exogenous transforming growth factor-beta 2 enhances connective tissue formation and wound strenth in guinea pig dermal wounds healing by secondary intent- Ann Surg 211:288-294.
45. Massler M, Schour I 1951 The growth pattern of the cranial vault in the albino rat as measured by vital staining with alizarine red "S". Anat Rec 110:83-101.
46. Kokich VG 1990 The biology of sutures. In: Cohen MM (ed.) Craniosynostosis: Diagnosis, evaluation and management. Raven Press, New York, NY, U.S.A., pp. 81-103.
47. Alberius P, Johneil O 1990 Immunohistochemical assessment of cranial suture development in rats. J Anat 173:61-68.
48. Moss ML 1960 Inhibition and stimulation of sutural fusion in the rat calvaria. Anat Rec 136:457-468.
49. Moss ML 1958 Fusion of the frontal suture in the rat. Am J Anat 102:141-166.
50. Mullink H, Henzen-Logmans SC, Tadema TM, Mol JJ, Meijer CJLM 1985 Influence of fixation and decalcification on the immunohistochemical staining of cell-specific marker in paraffin-embedded human bone biopsies. J Histochem Cytochem 33:1103-1109.
51. Bonewald LF, Mundy GR 1990 Role of transforming growth factor-beta in bone remodeling. Clin Orthop Rel Res 250:261-276.
52. Markens IS, Oudhof HAJ 1979 A study of the Occurrence of alkaline phophatase in the sutura interfrontalis of Wistar rats. Acta Anat 104:431-438.
53. Centrella M, Horowitz MC, Wozney JM, McCarthy TL 1994 Transforming growth factor-β gene family members and bone. Endocr Rev 15:27-37.
54. Opperman LA, Sweeney TM, Redmon J, Persing JA, Ogle RC 1993 Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dynam 198:312-322.
55. Opperman LA, Passarelli RW, Morgan EP, Reintjes M, Ogle RC 1995 Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Miner Res 10:1978-1987.
56. Roth DA, Bradley JP, Levine JP, McCarthy JG, Longaker MT 1995 Studies in cranial suture biology II: The role of the dura in cranial suture fusion. Plast Reconstr Surg 97:693-699.
57. Reid CA, McCarthy JG, Kolber AB 1981 A study of regeneration in parietal bone defects in rabbits. Plast Reconstr Surg 67:591-596.
58. Hobar PC, Schreiber JS, McCarthy JG, Thomas PA 1993 The role of the dura in cranial bone regeneration in the immature animal. Plast Reconstr Surg 92:405-410.
59. Roth DA, Gold LI, Han VKH, McCarthy JG, Sung JJ, Wisoff JH, Longaker MT 1996 Studies in cranial suture biology: Immunolocalization of transforming growth factor-β1, β2, β3 and insulin like growth factor-1 in premature cranial suture fusion. Plast Reconstr Surg (in press).
60. De Pollack C, Renier D, Hott M, Marie PJ 1996 Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosysnostosis). J Bone Miner Res 11:401-407.
61. Rutland P, Pulleyn LJ, Reardon W, Baraitser M, Hayward R, Jones B, Malcolm S, Winter RM, Oldridge M, Slaney SF, Poole MD, Wilkie AOM 1995 Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nature Genet 9:173-176.
62. Wilkie AOM, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Malcolm S, Winter RM, Reardon W 1995 Apert syndrome results form localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet 9:165-172.
63. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MWJ, Doetschman T 1995 Transforming growth factor-β3 is required for secondary palate fusion. Nature Genet 11:409-414.